Sofinnova forms Sofinnova Capital VII fund
Client(s) Sofinnova Partners
Jones Day advised Sofinnova Partners in the formation of Sofinnova Capital VII, a proposed €240 million venture capital fund focused on industrial biotechnology clean energy.
Cases & Deals
Contacts
Practices
Locations
Before sending, please note:
Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.